Pulmonary tumor thrombotic microangiopathy: the diagnosis that is usually made at autopsy
Why it happens
The tumor is inside the vessel wall, not in the lung tissue. The emboli are microscopic and non-occlusive at first; the occlusion is the wall's reaction to them, driven by platelet-derived growth factor (PDGF) and vascular endothelial growth factor (VEGF). That is why the angiogram shows no clot, why platelets are consumed, and why a PDGF blocker is part of the story below. Described by von Herbay in 1990 from autopsies of carcinoma patients; gastric adenocarcinoma in 59% of the reported cases, then breast and lung.
The picture, when it was reported
PTTM, as a checklist: Pressure, Thrombocytopenia, Tree-in-bud, Mucinous carcinoma.Pulmonary hypertension on the echo, platelets falling, centrilobular nodules on the CT, a mucin-producing adenocarcinoma. Four letters, four findings; three of them in a cancer patient with a clean angiogram is enough to act.
From the scan to the name
Why the week matters
Median 3 weeks from first symptom to death.96 reported cases with the interval known (Godbole 2019); the average was 9.5 weeks because of a few long survivors. Nobody has measured the delay from diagnosis to treatment, but with a median course of three weeks, a clinic slot in two weeks is most of the survival.
Sources
Retrieved from PubMed, read on Oct 15, 2026.
- Godbole RH, Saggar R, Kamangar N. Pulmonary tumor thrombotic microangiopathy: a systematic review. Pulm Circ 2019. doi:10.1177/2045894019851000
- Price LC, Wells AU, Wort SJ. Pulmonary tumour thrombotic microangiopathy. Curr Opin Pulm Med 2016. doi:10.1097/MCP.0000000000000297
- von Herbay A, et al. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer 1990. doi:10.1002/1097-0142(19900801)66:3<587::aid-cncr2820660330>3.0.co;2-j
- Minatsuki S, et al. Platelet-derived growth factor receptor-tyrosine kinase inhibitor, imatinib, is effective for treating pulmonary hypertension induced by pulmonary tumor thrombotic microangiopathy. Int Heart J 2015. doi:10.1536/ihj.14-220
- Chinen K, et al. Pulmonary tumor thrombotic microangiopathy in patients with gastric carcinoma: an analysis of 6 autopsy cases and review of the literature. Pathol Res Pract 2010. doi:10.1016/j.prp.2010.05.002
Bilirubin that climbs while the transaminases fall
The usual order of events
The enzymes leak out when cells die and clear from blood in days. Bilirubin rises as the surviving liver fails to excrete it, and the conjugated (direct) fraction dominates, because the block is in the hepatocyte's export step and in the small bile canaliculi. A direct-predominant bilirubin does not, by itself, separate injury from obstruction.
Tail, or something new?
Alkaline phosphatase stable or falling.
Ducts not dilated on ultrasound.
INR stable, patient awake, no new pain or fever.
Dilated ducts, a stone, a mass at the hilum.
Sepsis: cholestasis with a modest enzyme rise and a sick patient.
Tumor infiltrating the liver: alkaline phosphatase and LDH lead.
Indirect-predominant bilirubin: hemolysis, not the liver.
INR rising, new confusion: the liver is failing, whatever the cause.
Hy's law: transaminases above 3 times normal plus bilirubin above 2 times normal, hepatocellular pattern, with no obstruction, hemolysis, virus or other liver disease to explain it, from a drug.About 1 in 10 of these patients dies or needs a transplant: Zimmerman's observation, adopted by the regulators (Temple 2006). In the US Drug-Induced Liver Injury Network, meeting Hy's law predicted death or transplant within 2 years in 10%, and 14% with the R-ratio version; across all 1,089 drug injuries, jaundiced or not, 9.8% died or were transplanted, two thirds of them from the liver (Hayashi 2017).
What to do on the morning the bilirubin jumps
Sources
Retrieved from PubMed, read on Oct 15, 2026.
- Temple R. Hy's law: predicting serious hepatotoxicity. Pharmacoepidemiol Drug Saf 2006. doi:10.1002/pds.1211
- Hayashi PH, et al. Death and liver transplantation within 2 years of onset of drug-induced liver injury. Hepatology 2017. doi:10.1002/hep.29283
- Andrade RJ, et al. Drug-induced liver injury. Nat Rev Dis Primers 2019. doi:10.1038/s41572-019-0105-0
Hemoglobin electrophoresis after a transfusion is a mixture
Two ways to get a false normal
Transfused cells are of every age, so their average remaining life is about 60 days: most are gone by 3 months, all by 4. Iron deficiency lowers hemoglobin A2 by a few tenths of a percent, which matters only in the borderline zone, but that is where carriers sit. The screening guideline asks for the A2 to be interpreted with a ferritin from the same draw, and repeated after iron repletion when the cell size does not recover. DNA testing (globin genotyping) is affected by neither.
Reading the blood count before the electrophoresis
Red cell count high (above 5 million).
RDW normal: the cells are uniformly small.
Mentzer index (MCV divided by red cell count in millions) below 13 (Mentzer 1973).
Red cell count low.
RDW high: a mixed population of old normal and new small cells.
Mentzer index above 13. Ferritin low.
Order it right
Sources
Retrieved from PubMed, read on Oct 15, 2026.
- Mentzer WC Jr. Differentiation of iron deficiency from thalassaemia trait. Lancet 1973. doi:10.1016/s0140-6736(73)91446-3
- Ryan K, et al. Significant haemoglobinopathies: guidelines for screening and diagnosis. British Committee for Standards in Haematology. Br J Haematol 2010. doi:10.1111/j.1365-2141.2009.08054.x
- Origa R. Beta-Thalassemia. GeneReviews, University of Washington, updated 2024. NCBI Bookshelf NBK1426
Anticoagulation while breastfeeding
Three drugs, one question
Big or bound.Heparin is too big for milk; warfarin is too bound. The direct oral anticoagulants are neither.
Decide at the bedside
How long: at least 3 months, and at least 6 weeks postpartum, whichever is longer.A clot after delivery is provoked by pregnancy, surgery and immobility; the risk is highest in the first 6 weeks and persists to 12. It does not need indefinite treatment unless something else turns up: a second event, or persistent antiphospholipid antibodies, which also rule out a later switch to a direct oral anticoagulant. Thrombophilia testing in the acute phase does not change the first 3 months; that result is hematology's call later, not day one's.
A superficial clot in a pregnant or postpartum leg gets a duplex of the deep system, and heparin.The same guideline suggests low molecular weight heparin over no anticoagulant for superficial vein thrombosis in pregnancy and after delivery; cesarean, preeclampsia or gestational hypertension, and a superficial clot in the days before are all part of one provoked story.
Sources
Retrieved from PubMed, read on Oct 15, 2026.
- Bates SM, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: venous thromboembolism in the context of pregnancy. Blood Adv 2018. doi:10.1182/bloodadvances.2018024802
- Bates SM, et al. VTE, thrombophilia, antithrombotic therapy, and pregnancy. Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: ACCP guidelines. Chest 2012. doi:10.1378/chest.11-2300
- Wiesen MH, et al. The direct factor Xa inhibitor rivaroxaban passes into human breast milk. Chest 2016. doi:10.1016/j.chest.2016.01.021